HA Peptide TFA
|
H659313-5mg
|
≥99% |
N/A |
5mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
HA Peptide TFA
|
H659313-10mg
|
≥99% |
N/A |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
Human IgG4 kappa, Isotype Control
|
H659277-1mg
|
≥95% |
N/A |
1mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Human PD-L1 inhibitor V TFA
|
H659264-10mg
|
≥96% |
N/A |
10mg
|
¥ 2900.9
|
期货,请咨询 |
阿拉丁 |
HS024 TFA
|
H659246-5mg
|
≥99% |
N/A |
5mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
HS024 TFA
|
H659246-1mg
|
≥99% |
N/A |
1mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
HS024 TFA
|
H659246-10mg
|
≥99% |
N/A |
10mg
|
¥ 5200.9
|
期货,请咨询 |
阿拉丁 |
Homocarnosine TFA
|
H659245-5mg
|
≥98% |
3650-73-5 |
5mg
|
¥ 1799.9
|
现货 |
阿拉丁 |
Homocarnosine TFA
|
H659245-50mg
|
≥98% |
3650-73-5 |
50mg
|
¥ 9359.9
|
现货 |
阿拉丁 |
Homocarnosine TFA
|
H659245-25mg
|
≥98% |
3650-73-5 |
25mg
|
¥ 5849.9
|
现货 |
阿拉丁 |
Homocarnosine TFA
|
H659245-10mg
|
≥98% |
3650-73-5 |
10mg
|
¥ 2879.9
|
现货 |
阿拉丁 |
Hoechst 34580 tetrahydrochloride
|
H659244-5mg
|
≥99% |
2310135-08-9 |
5mg
|
¥ 600.9
|
期货,请咨询 |
阿拉丁 |
Hoechst 34580 tetrahydrochloride
|
H659244-50mg
|
≥99% |
2310135-08-9 |
50mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
Hoechst 34580 tetrahydrochloride
|
H659244-10mg
|
≥99% |
2310135-08-9 |
10mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
Hoechst 34580 tetrahydrochloride
|
H659244-100mg
|
≥99% |
2310135-08-9 |
100mg
|
¥ 3400.9
|
期货,请咨询 |
阿拉丁 |
hsa-miR-155-5p mimic
|
H659241-5nmol
|
≥99% |
N/A |
5nmol
|
¥ 2200.9
|
期货,请咨询 |
阿拉丁 |
hsa-miR-140-5p mimic
|
H659172-5nmol
|
≥96% |
N/A |
5nmol
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
hsa-miR-145-5p mimic
|
H659167-5nmol
|
≥95% |
N/A |
5nmol
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
hsa-miR-143-3p mimic
|
H659086-5nmol
|
≥97% |
N/A |
5nmol
|
¥ 2100.9
|
期货,请咨询 |
阿拉丁 |
HKSOX-1m (5/6-mixture) (hydrobromide)
|
H659079-1mg
|
≥97% |
N/A |
1mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
hsa-miR-26b-5p mimic
|
H659070-5nmol
|
≥98% |
N/A |
5nmol
|
¥ 3100.9
|
期货,请咨询 |
阿拉丁 |
hsa-miR-140-3p mimic
|
H659045-5nmol
|
≥99% |
N/A |
5nmol
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
Harmane-d
|
H659037-5mg
|
≥98% |
N/A |
5mg
|
¥ 19000.9
|
期货,请咨询 |
阿拉丁 |
Harmane-d
|
H659037-10mg
|
≥98% |
N/A |
10mg
|
¥ 30500.9
|
期货,请咨询 |
阿拉丁 |